Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure

This publication has 15 references indexed in Scilit:

• Cardiovascular effects of recombinant human erythropoietin in predialysis patients
  American Journal of Kidney Diseases, 1997
• The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
  Published by Elsevier ,1996
• Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
  Kidney International, 1995
• Follow-Up of Cardiac Changes Induced by Anemia Compensation in Normotensive Hemodialysis Patients with Left-Ventricular Hypertrophy
  Nephron, 1993
• Influence of Long-Term Amelioration of Anemia and Blood Pressure Control on Left Ventricular Hypertrophy in Hemodialyzed Patients
  Nephron, 1992
• Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
  New England Journal of Medicine, 1990
• Impact of left ventricular hypertrophy on survival in end-stage renal disease
  Kidney International, 1989
• Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
  Circulation, 1978
• Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
  Circulation, 1977
• Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy
  The American Journal of Cardiology, 1976